Specifically, S100A8 aggravated hepatitis in high fat and cholesterol-fed mice 28, while S100A11 spurs hepatic steatosis via the RAGE-mediated AKT-mTOR signaling axis 29. Here, S100A8 is linked to fatty liver disease.